ArticleWorld journal of gastrointestinal oncology2025
Efficacy and safety of donafenib plus transarterial chemoembolization and immunotherapy for hepatocellular carcinoma.
Zhi-Hao Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.